Literature DB >> 33339432

Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue.

Rafael Franco1,2, Alejandro Lillo1, Rafael Rivas-Santisteban1,2, Ana I Rodríguez-Pérez2,3, Irene Reyes-Resina1,4, José L Labandeira-García2,3, Gemma Navarro2,5.   

Abstract

Angiotensin-converting enzyme 2 (ACE2) is a membrane peptidase and a component of the renin-angiotensin system (RAS) that has been found in cells of all organs, including the lungs. While ACE2 has been identified as the receptor for severe acute respiratory syndrome (SARS) coronaviruses, the mechanism underlying cell entry remains unknown. Human immunodeficiency virus infects target cells via CXC chemokine receptor 4 (CXCR4)-mediated endocytosis. Furthermore, CXCR4 interacts with dipeptidyl peptidase-4 (CD26/DPPIV), an enzyme that cleaves CXCL12/SDF-1, which is the chemokine that activates this receptor. By analogy, we hypothesized that ACE2 might also be capable of interactions with RAS-associated G-protein coupled receptors. Using resonance energy transfer and cAMP and mitogen-activated protein kinase signaling assays, we found that human ACE2 interacts with RAS-related receptors, namely the angiotensin II type 1 receptor (AT1R), the angiotensin II type 2 receptor (AT2R), and the MAS1 oncogene receptor (MasR). Although these interactions lead to minor alterations of signal transduction, ligand binding to AT1R and AT2R, but not to MasR, resulted in the upregulation of ACE2 cell surface expression. Proximity ligation assays performed in situ revealed macromolecular complexes containing ACE2 and AT1R, AT2R or MasR in adult but not fetal mouse lung tissue. These findings highlight the relevance of RAS in SARS-CoV-2 infection and the role of ACE2-containing complexes as potential therapeutic targets.

Entities:  

Keywords:  ACE2; COVID-19; Mas receptor; RAS; SARS-CoV-2 receptor; angiotensin receptor; lung

Year:  2020        PMID: 33339432     DOI: 10.3390/ijms21249602

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  9 in total

Review 1.  Adenosine A2A receptor as a potential target for improving cancer immunotherapy.

Authors:  Muhammad Atif; Abdullah Alsrhani; Farrah Naz; Muhammad Ikram Ullah; Ayman Ali Mohammed Alameen; Muhammad Imran; Hasan Ejaz
Journal:  Mol Biol Rep       Date:  2022-06-25       Impact factor: 2.316

2.  Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT4R) in the postmortem brains of individuals without cognitive impairment.

Authors:  Caglar Cosarderelioglu; Lolita S Nidadavolu; Claudene J George; Ruth Marx-Rattner; Laura Powell; Qian-Li Xue; Jing Tian; Esther S Oh; Luigi Ferrucci; Pervin Dincer; David A Bennett; Jeremy D Walston; Peter M Abadir
Journal:  Geroscience       Date:  2022-08-15       Impact factor: 7.581

3.  Relationship between ENaC Regulators and SARS-CoV-2 Virus Receptor (ACE2) Expression in Cultured Adult Human Fungiform (HBO) Taste Cells.

Authors:  Mehmet Hakan Ozdener; Sunila Mahavadi; Shobha Mummalaneni; Vijay Lyall
Journal:  Nutrients       Date:  2022-06-29       Impact factor: 6.706

4.  Higher Angiotensin II Type 1 Receptor Levels and Activity in the Postmortem Brains of Older Persons with Alzheimer's Dementia.

Authors:  Caglar Cosarderelioglu; Lolita S Nidadavolu; Claudene J George; Ruth Marx-Rattner; Laura Powell; Qian-Li Xue; Jing Tian; Joy Salib; Esther S Oh; Luigi Ferrucci; Pervin Dincer; David A Bennett; Jeremy D Walston; Peter M Abadir
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-04-01       Impact factor: 6.591

5.  Losartan Mitigates Oxidative Stress in the Brains of Aged and Inflamed IL-10-/- Mice.

Authors:  Nazaneen Saleh; Caglar Cosarderelioglu; Ramya Vajapey; Jeremy Walston; Peter M Abadir
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-09-01       Impact factor: 6.591

6.  Interactions between ibuprofen, ACE2, renin-angiotensin system, and spike protein in the lung. Implications for COVID-19.

Authors:  Rita Valenzuela; Maria A Pedrosa; Pablo Garrido-Gil; Carmen M Labandeira; Gemma Navarro; Rafael Franco; Ana I Rodriguez-Perez; Jose L Labandeira-Garcia
Journal:  Clin Transl Med       Date:  2021-04

7.  ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors.

Authors:  Andrea Estefanía Portales; Emilio Román Mustafá; Clara Inés McCarthy; María Paula Cornejo; Paula Monserrat Couto; Mariela Mercedes Gironacci; Julio Javier Caramelo; Mario Perelló; Jesica Raingo
Journal:  Life Sci       Date:  2022-01-14       Impact factor: 5.037

Review 8.  Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment.

Authors:  Jose L Labandeira-Garcia; Carmen M Labandeira; Rita Valenzuela; Maria A Pedrosa; Aloia Quijano; Ana I Rodriguez-Perez
Journal:  Biomedicines       Date:  2022-02-21

Review 9.  Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal.

Authors:  Sergio Pandolfi; Salvatore Chirumbolo; Giovanni Ricevuti; Luigi Valdenassi; Geir Bjørklund; Roman Lysiuk; Monica Daniela Doşa; Larysa Lenchyk; Serafino Fazio
Journal:  Basic Clin Pharmacol Toxicol       Date:  2021-12-02       Impact factor: 3.688

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.